Deal Making

Featured on Deal Making

Industry consortium takes aim at lowering CGT production costs
Deal-Making
Industry consortium takes aim at lowering CGT production costsIndustry consortium takes aim at lowering CGT production costs

GSK, Cytiva, and Lonza are among 20 companies looking to develop technologies aimed at lowering the cost of cell and gene therapy production.

byMillie Nelson, Editor

More from Deal Making

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.